Macaso, Mario .

HRN: 23-06-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2023
CEFTAZIDIME 1GM (VIAL)
05/18/2023
05/25/2023
IV
1g
TID
Empiric
Waiting Final Action 
05/18/2023
AZITHROMYCIN 500MG TABLET (TAB)
05/18/2023
05/22/2023
PO
500mg
OD
Empiric
Waiting Final Action 
05/19/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/19/2023
05/19/2023
IV
4.5gms
LD
T/C Sepsis
Waiting Final Action 
05/19/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/19/2023
05/26/2023
IV
2.25gms
Q8
T/C Sepsis
Waiting Final Action 
05/21/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/21/2023
06/04/2023
IV
4.5g
Q6
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: